During a live event, Matthew Galsky, MD discussed neoadjuvant and adjuvant options for a patient case including nivolumab or dose-dense MVAC.

A scientific statement has been published by the AHA regarding cardiovascular toxicity in patients treated for childhood cancer.

The addition of serial circulating tumor DNA assays to imaging surveillance offered little benefit to patients with stage II ...

Oncology nurses and APPs can enhance patients’ comfort by counseling patients on what integrative care is and working to make those options accessible.

Lower odds of screening seen in association with lack of health insurance, being rural resident, not having a clinician.

Less than one-quarter of oncologists surveyed indicated that every one of their patients with advanced gastric or gastroesophageal junction cancers received biomarker testing consistent with practice ...

The teams played to scoreless draw in the first leg of their CONCACAF tournament match last week in Carson, and the Galaxy ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced the creation of a new Sarcoma Subcommittee ...

Distinguished, highly accomplished clinician with stellar track record of successfully leading numerous registrational trials through global ...

Guidelines created by a multi-disciplinary panel of specialists focus on implementation of novel treatments and technologies for which level 1 evidence is lacking.

The only update for patients with stage IV NSCLC without driver alterations is that patients who have HER2-overexpressing (IHC 3+) disease and good performance status can receive trastuzumab ...